Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 6

The role of interleukin-9 and interleukin-17 in myocarditis with different etiologies

Farklı etyolojilerle oluşan miyokarditlerde interlökin-9 ve interlökin-17’nin rolü

Pages
797–802
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum samples of the patientswere taken during diagnosis in order to analyze serum IL-9and IL-17 levels and sedimentation rate, CRP, ASO, proBNP, CK-MB, and Troponin-I tests were performed.Results: It was found that IL-17 levels were statisticallysignificant in all acute rheumatic fever, Myocarditisand Kawasaki patients compared to the control group(p = 0.001) and that cut-off was 4.30 pg/mL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Myocarditis is an inflammatory disease of thecardiac muscle.
📊
Key Findings & Data:Our aim with thisstudy was to determine interleukin-9 (IL-9) and interleukin-17(IL-17) levels in myocarditis cases with different etiologies.Materials and methods: Thirty one patients with myocarditis and 30 healthy controls of similar age and genderwithout a history of chronic disease were included in thestudy.
💡
Conclusion & Impact:Serum samples of the patientswere taken during diagnosis in order to analyze serum IL-9and IL-17 levels and sedimentation rate, CRP, ASO, proBNP, CK-MB, and Troponin-I tests were performed.Results: It was found that IL-17 levels were statisticallysignificant in all acute rheumatic fever, Myocarditisand Kawasaki patients compared to the control group(p = 0.001) and that cut-off was 4.30 pg/mL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Myocarditis is an inflammatory disease of thecardiac muscle. Prognosis is most often good but, in somepatients, the disease can be fulminant. Our aim with thisstudy was to determine interleukin-9 (IL-9) and interleukin-17(IL-17) levels in myocarditis cases with different etiologies.Materials and methods: Thirty one patients with myocarditis and 30 healthy controls of similar age and genderwithout a history of chronic disease were included in thestudy. All 31 patients were clinically myocarditis. In some ofthese patients, the cause of myocarditis is acute rheumaticfever or Kawasaki disease. Serum samples of the patientswere taken during diagnosis in order to analyze serum IL-9and IL-17 levels and sedimentation rate, CRP, ASO, proBNP, CK-MB, and Troponin-I tests were performed.Results: It was found that IL-17 levels were statisticallysignificant in all acute rheumatic fever, Myocarditisand Kawasaki patients compared to the control group(p = 0.001) and that cut-off was 4.30 pg/mL. This valuewas determined to be 71% sensitive and 67% specific forIL-17 (AUC = 0.761).Conclusions: Both of the mean and median levels ofIL-17 were significantly higher in pediatric patients withmyocarditis than in healthy children. Our study made usthink that complications of myocarditis and associatedmorbidity can be prevented by IL17 inhibitors. The highlevels of IL17 found in our study may be a reference forfuture study.

Özet

Amaç: Miyokardit, kalp kasını tutan inflamatuar bir hastalıktır. Prognoz genel olarak iyidir, ancak bazı hastalarda hastalık fulminant seyredebilir. Bu çalışma ile amacımız, farklı etiyolojili miyokardit olgularında IL-9 ve IL-17 düzeylerini belirlemektir. Gereç ve yöntem: Çalışmaya 31 miyokarditli hasta ve kronik hastalık öyküsü olmayan benzer yaş ve cinsiyet te 30 sağlıklı kontrol dahil edildi. 31 hastanın tümü klinik olarak miyokardit idi. Bu hastaların bazılarında, miyokarditin nedeni akut romatizmal ateş veya Kawasaki hastalığıdır. Serum IL-9 ve IL-17 düzeylerini analiz etmek için tanı sırasında serum örnekleri alındı ve sedimantasyon hızı, CRP, ASO, pro-BNP, CK-MB ve Troponin-I testleri yapıldı. Bulgular: Kontrol grubu ile karşılaştırıldığında Akut romatizmal ateş, Kawasaki ve diğer nedenlerle oluşan tüm miyokardit hastalarında IL-17 düzeylerinin istatistiksel olarak anlamlı fark olduğu bulundu (p = 0.001) ve cut-of değeri 4.30 pg/mL idi. Bu değerin IL-17 için %71 duyarlı ve %67 spesifik olduğu tespit edildi (AUC = 0.761). Sonuçlar: Miyokarditli pediatrik hastalarda IL-17’nin ortalama ve ortanca düzeyleri sağlıklı çocuklardan anlamlı derecede yüksekti. Çalışmamız, miyokardit komplikasyonlarının ve myokardite bağlı morbiditenin IL-17 inhibitörleri tarafından önlenebileceğini düşündürdü. Çalışmamızda bulunan yüksek IL-17 düzeyleri gelecekteki çalışmalar için referans olabilir.

🔖

Cite This Article

AKKE, N. S., ACIPAYAM, C., KILINÇ, M., GÜLMEZ, T. K. (2022). The role of interleukin-9 and interleukin-17 in myocarditis with different etiologies. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 6, 797–802. https://ajindex.com/articles/620890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006;113:876–90
  2. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–5
  3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association. Circulation 2004;110:2747–71
  4. Mirkinson L. The diagnosis of rheumatic fever. Pediatr Rev 1998;19:310–1
  5. Amigo MC, Martínez-Lavín M, Reyes PA. Acute rheumatic fever. Rheum Dis Clin North Am 1993;19:333–50
  6. Xavier JL Jr, Matos Soeiro Ad, Lopes AS, Spina GS, Serrano CV Jr, Oliveira MT Jr. Clinically manifested myocarditis in acute rheumatic fever. Arq Bras Cardiol 2014;102:e17–20
  7. Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998;98:450–7
  8. Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr 2007;19:71–4
  9. Blank M, Aron-Maor A, Shoenfeld Y. From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus 2005;14:697–701
  10. Toor D, Sharma N. T cell subsets: an integral component in pathogenesis of rheumatic heart disease. Immunol Res 2018;66:18–30
  11. Korn T, Betteli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485–517
  12. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukocyte Biol 1995;57:353–360
  13. Knowlton KU, Badorff C. The immune system in viral myocarditis: maintaining the balance. Circ Res 1999;85: 559–61
  14. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998;188:1307–20
  15. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22:6